Boston Scientific Corp (BSX)vsenVVeno Medical Corp (NVNO)
BSX
Boston Scientific Corp
$69.78
+2.39%
HEALTHCARE · Cap: $101.28B
NVNO
enVVeno Medical Corp
$10.51
-9.08%
HEALTHCARE · Cap: $6.89M
Smart Verdict
WallStSmart Research — data-driven comparison
BSX leads profitability with a 14.4% profit margin vs 0.0%. BSX earns a higher WallStSmart Score of 63/100 (C+).
BSX
Buy63
out of 100
Grade: C+
NVNO
Avoid29
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+1.2%
Fair Value
$70.62
Current Price
$69.78
$0.84 discount
Intrinsic value data unavailable for NVNO.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Growing faster than its price suggests
15.9% revenue growth
Generating 1.0B in free cash flow
Reasonable price relative to book value
Areas to Watch
Premium valuation, high expectations priced in
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : BSX
The strongest argument for BSX centers on Market Cap, PEG Ratio, Revenue Growth. Revenue growth of 15.9% demonstrates continued momentum. PEG of 0.75 suggests the stock is reasonably priced for its growth.
Bull Case : NVNO
The strongest argument for NVNO centers on Price/Book.
Bear Case : BSX
The primary concerns for BSX are P/E Ratio.
Bear Case : NVNO
The primary concerns for NVNO are Revenue Growth, EPS Growth, Market Cap.
Key Dynamics to Monitor
BSX profiles as a growth stock while NVNO is a value play — different risk/reward profiles.
NVNO carries more volatility with a beta of 1.15 — expect wider price swings.
BSX is growing revenue faster at 15.9% — sustainability is the question.
BSX generates stronger free cash flow (1.0B), providing more financial flexibility.
Bottom Line
BSX scores higher overall (63/100 vs 29/100) and 15.9% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Boston Scientific Corp
HEALTHCARE · MEDICAL DEVICES · USA
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
enVVeno Medical Corp
HEALTHCARE · MEDICAL DEVICES · USA
enVVeno Medical Corp is a pioneering medical device company focused on revolutionizing vascular access solutions for dialysis patients through its proprietary biocompatible technology. Addressing critical unmet needs within the dialysis sector, enVVeno enhances both the safety and efficacy of vascular procedures, positioning itself for significant growth in the expanding vascular interventions market. With a commitment to advanced engineering and stringent regulatory compliance, the company is strategically aligned with the evolving healthcare landscape and is focused on improving patient outcomes in a vital area of medical care.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?